The fertility test market is expected to grow at a CAGR of 5.54% over the forecast period, reaching a market size of US$775.732 million in 2029 from US$531.831 million in 2022.
Fertility Testing is a process through which males and females are made aware of their reproductive health, which helps them detect ovulation and diagnose infertility. This procedure aids in planning pregnancy and helps doctors diagnose the cause of infertility as well. The growing age of the population and the declining fertility rate are expected to be the primary market drivers. This is because fertility testing can be considered a safe option to detect pregnancy or ovulation and infertility for people trying to get pregnant at an advanced age.
Besides that, the growing prevalence of PCOS and PCOD among females is considered another major factor that is driving up the fertility test market. Today, technology is thriving, and easy-to-use fertility monitors and kits are in wide demand in the fertility test market, thus constituting a vital growth factor for the fertility test market. In the past few years, fertility tourism has surged significantly, creating an opportunity for the fertility test market to grow at a notable rate in the coming years.
Another considerable contribution to this market is the growing self-health awareness among women. Government and authorities, at times, set up campaigns and awareness programs to provide the required self-health literacy to women in both developed and developing nations. With the increased awareness, the demand for fertility testing is projected to increase in the coming years.
Although the market includes several growth opportunities, one of the major restraints is that these tests, at times, can generate false results that can hamper the market growth in the future.
The decline in fertility rates in major countries around the globe has become a serious concern. The birth rate of 2.1 is considered an ideal rate for a country to naturally replace its population. As reported by the World Economic Forum, the United States’ most recent survey showed that its birth rate has been on a continuous decline for the past six years, and its current rate is at 1.6. The report also showed that the birth rate in China and Japan stands at 1.3, while that in Russia, Brazil, and Bangladesh stands at 1.6, 1.8, and 1.7, respectively.
One of the major reasons behind this is the growing age of the population, which has simultaneously contributed to the increasing age of first-time pregnancies. According to the World Bank, the old-age dependency ratio has increased significantly over the past few decades, and in 2020 it stood at 14.296%. This is expected to be a significant market driver as fertility tests can be considered a safe option to detect the early signs of ovulation and infertility among the high-age population.
PCOS is one of the major causes of infertility among females. PCOS, or Polycystic Ovary Syndrome, is a hormonal disorder that causes enlarged ovaries and small cysts on the outer edges, due to which the ovaries fail to release eggs, which hampers the menstrual cycle and thereby increases the chances of infertility among women.
According to the Centers for Disease Control and Prevention, PCOS affects around 6%-12% (around 5 million) of American women. Since fertility tests can contribute as a primary source of information regarding ovulation and infertility, the prevalence of PCOS is directly related to the high demand for fertility tests in the coming years.
Fertility Tourism, or cross-border reproductive care tourism, is traveling from one country to another to overcome fertility issues and get fertility treatment. This practice has become popular in the past few decades owing to factors like strict regulations in domestic countries, better treatment facilities in foreign countries, etc. To work on infertility issues and conceiving problems, fertility tourism involves a high-scale application of fertility tests, which can positively impact its market in the forecasted period.
Although the Fertility tests help to get the required information about fertility and ovulation, at times, these tests can detect false results as well. This problem generally arises in home urine test kits. There can be several causes, like user error, chemical pregnancy, fertility medications, and recent pregnancies, that may leave behind hCG in the body. These factors can contribute to the high probability of false result generation, which can hamper market growth.
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2022 | US$9.809 billion |
| Market Size Value in 2029 | US$15.227 billion |
| Growth Rate | CAGR of 6.48% from 2022 to 2029 |
| Study Period | 2019 to 2029 |
| Historical Data | 2019 to 2022 |
| Base Year | 2023 |
| Forecast Period | 2024 – 2029 |
| Forecast Unit (Value) | USD Billion |
| Segments Covered |
|
| Companies Covered | |
| Regions Covered | North America, South America, Europe, Middle East and Africa, Asia Pacific |
| Customization Scope | Free report customization with purchase |
Fertility Test Market Segmentation: